Related Experiment Video
Updated: Aug 17, 2025

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Natural essential oils as a new therapeutic tool in colorectal cancer
Stefania Garzoli1, Pedro Alarcón-Zapata2,3, Gulnaz Seitimova4
1Department of Drug Chemistry and Technologies, University "Sapienza" of Rome, P.Le Aldo Moro 5, 00185, Rome, Italy.
Abstract:
Colorectal cancer (CRC) is the third most revalent type of cancer in the world and the second most common cause of cancer death (about 1 million per year). Historically, natural compounds and their structural analogues have contributed to the development of new drugs useful in the treatment of various diseases, including cancer. Essential oils are natural odorous products made up of a complex mixture of low molecular weight compounds with recognized biological and pharmacological properties investigated also for the prevention and treatment of cancer. The aim of this paper is to highlight the possible role of essential oils in CRC, their composition and the preclinical studies involving them. It has been reviewed the preclinical pharmacological studies to determine the experimental models used and the anticancer potential mechanisms of action of natural essential oils in CRC. Searches were performed in the following databases PubMed/Medline, Web of science, TRIP database, Scopus, Google Scholar using appropriate MeSH terms. The results of analyzed studies showed that EOs exhibited a wide range of bioactive effects like cytotoxicity, antiproliferative, and antimetastatic effects on cancer cells through various mechanisms of action. This updated review provides a better quality of scientific evidence for the efficacy of EOs as chemotherapeutic/chemopreventive agents in CRC. Future translational clinical studies are needed to establish the effective dose in humans as well as the most suitable route of administration for maximum bioavailability and efficacy. Given the positive anticancer results obtained from preclinical pharmacological studies, EOs can be considered efficient complementary therapies in chemotherapy in CRC.
Insights
Essential oils (EOs) show promise as complementary therapies for colorectal cancer (CRC). Preclinical studies reveal EOs possess cytotoxic and antiproliferative effects against cancer cells, warranting further clinical investigation.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death globally.
- Natural compounds have historically informed cancer drug development.
- Essential oils (EOs) are complex natural mixtures with known biological activities, including potential anticancer properties.
Purpose of the Study:
- To review the composition and preclinical evidence of essential oils in colorectal cancer (CRC).
- To explore the anticancer mechanisms and experimental models used in studies of EOs for CRC.
- To highlight the potential of EOs as chemotherapeutic or chemopreventive agents for CRC.
Main Methods:
- Systematic review of preclinical pharmacological studies.
- Searches conducted in major scientific databases (PubMed/Medline, Web of Science, Scopus, Google Scholar, TRIP database).
- Utilized relevant Medical Subject Headings (MeSH) terms for comprehensive literature retrieval.
Main Results:
- Essential oils demonstrated significant cytotoxic, antiproliferative, and antimetastatic effects on colorectal cancer cells in preclinical models.
- Various mechanisms of action were identified for the anticancer effects of EOs.
- The reviewed studies provide robust scientific evidence for the efficacy of EOs against CRC.
Conclusions:
- Essential oils show considerable potential as effective complementary therapies in CRC treatment.
- Further translational clinical studies are necessary to determine optimal human dosage and administration routes for EOs.
- EOs represent a promising avenue for chemoprevention and adjuvant chemotherapy in colorectal cancer management.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...